Notification of Intent to Consolidate Requirements – HCD-W Cost-Per-Reportable-Results Chemistry Testing Supplies
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Health Agency (DHA) Contracting Activity is preparing to consolidate the procurement of clinical chemistry analyzers and associated reagents, consumables, and maintenance services across twenty-four military treatment facilities within the Healthcare Contracting Division – West area of responsibility into two to three consolidated single-award delivery orders under the Department of Veterans Affairs Federal Supply Schedule Group 66, Part III, Category 605-1A. This consolidation, justified under the Revolutionary FAR Overhaul provisions, aims to eliminate inefficiencies from fragmented, facility-specific contracts by standardizing equipment and pricing models, specifically instituting a cost-per-reportable-result structure to enhance cost transparency and reduce administrative burden. The acquisition will split requirements based on analyzer type: wet chemistry with automation, wet chemistry without automation, and dry chemistry, with the wet chemistry category subject to a single solicitation and potential one- or two-award outcome depending on whether a single vendor can meet both automation requirements. The anticipated solicitation number is HT941026Q2031, scheduled for release on or about May 6, 2026, via GSA eBuy, and will be accompanied by the approved Determination and Findings document that details the rationale, market research, and anticipated benefits, including estimated savings of over 30% and improved equipment uptime and standardization. Market research has confirmed the absence of small business participation in this category, with all current suppliers under the VA FSS identified as large businesses, resulting in a formal determination that no small business set-asides are feasible. As such, no small business set-aside will be used, and the procurement will be conducted as a full and open competition without restriction. Performance will be delivered directly to the twenty-four MTFs across California, Arizona, Washington, Hawaii, and Alaska, with the primary point of performance in San Diego, California. The delivery orders are structured with a 12-month base period and up to six additional 12-month option periods, permitting a total potential performance duration of seven years. Evaluation will be based on a best value trade-off approach, balancing technical capability, including automation level, accuracy, uptime, and maintenance complexity, against cost performance under the CPRR model, ensuring outcomes align with clinical quality and financial efficiency. Contract administration will be managed by DHA through the primary contacts Kennette “Khay” Esguerra and Michelle Sanders, with no specific packaging, marking, invoicing, or security requirements outlined in the pre-solicitation notice,
General Info
Agency
NAICS
Place of Performance
San Diego, CA, 92134, USASet-Aside
Timeline
Organization & Contact Information
Full Description
NOTICE OF INTENT TO CONSOLIDATE CONTRACT REQUIREMENTS
1. INTRODUCTION
This is a Special Notice of Intent to Consolidate contract requirements. This notice is issued for informational and planning purposes only in accordance with the Revolutionary FAR Overhaul (RFO) FAR 7.107-3(b), "Notification to the public."
THIS IS NOT A SOLICITATION FOR OFFERS/PROPOSALS/QUOTES AND NO CONTRACT WILL BE AWARDED FROM THIS NOTICE. No proposals or quotes are being requested or accepted with this notice. The Government is not obligated to and will not pay for any information received from potential sources as a result of this notice.
2. NOTIFICATION OF CONSOLIDATION
Pursuant to RFO FAR 7.107-3(b)(1), the Defense Health Agency (DHA) Contracting Activity (CA), hereby provides public notification that the Senior Procurement Executive (SPE) has formally determined that the consolidation of contract requirements for clinical chemistry analyzer requirements for twenty-four (24) military treatment facilities (MTFs) within the DHACA Healthcare Contracting Division - West (HCD-W) area of responsibility (AOR) into two (2) to three (3)* consolidated single-award delivery orders utilizing the Department of Veterans Affairs (VA) Federal Supply Schedule (FSS) Group 66, Part III (66-III) contracts under category 605-1A for high maintenance/complexity clinical chemistry analyzers is necessary and justified. The delivery orders will be consolidated based on MTF requirements as follows:
• MTFs requiring wet chemistry analyzers with automation
• MTFs requiring wet chemistry analyzers without automation
• MTFs requiring dry chemistry analyzers
* Note: The wet chemistry analyzer requirements will be procured under a single solicitation. After evaluation of the quotes received, a best value determination will be made to determine if it is in the Government’s best interest to award a single delivery order for wet chemistry analyzers (with both automation and without automation) when the awardee is the same vendor or to award two (2) separate delivery orders for wet chemistry analyzers (one (1) with automation and one (1) without automation) when the awardees are two different vendors.
3. JUSTIFICATION & ANTICIPATED BENEFITS
See attached approved Determination & Findings (D&F) Consolidation of Requirements document for detailed justification and anticipated benefits of this consolidated acquisition approach.
4. SMALL BUSINESS INCLUSION
DHA is committed to maximizing small business participation. The result of the extensive market research conducted is documented in the attached D&F document, which determines that there are no small businesses performing on any of the clinical chemistry analyzer contract actions covering the MTFs within the AOR.
5. UPCOMING SOLICITATION
The anticipated solicitation number is HT941026Q2031 and will be posted on GSA eBuy. The Government anticipates releasing the official solicitation for this consolidated requirement on or about 6 May 2026. The approved D&F document justifying this consolidation will be published concurrently with the solicitation as required by RFO FAR 7.107-3(b)(2).
6. POINT OF CONTACT
For questions regarding this notice, please contact Contract Specialist, Kennette “Khay” Esguerra at kennette.m.esguerra.civ@health.mil and/or Contracting Officer, Michelle Sanders at michelle.e.sanders6.civ@health.mil.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Health Agency (dha)
Same awarding agency